Juan Bahamon
Neurology · Cleveland, TXNPI 1548376130
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 369 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $5,674 and has fallen 96.0% since, to $229 in 2025.
Across 369 payments — averaging $21.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$680
- AstraZeneca$589
- Novartis$572
- Biogen$533
- Sanofi$424
- plus $4K from 32 others
What the payments were for
- Travel & lodging$871%
- Food & beverage$7,99399%
- Education$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EMD Serono, Inc. | 62 | $1,140 |
| Teva Pharmaceuticals USA, Inc. | 29 | $680 |
| AstraZeneca | 15 | $589 |
| Novartis | 26 | $572 |
| Biogen | 19 | $533 |
| Sanofi | 16 | $424 |
| Genentech USA, Inc. | 20 | $376 |
| AbbVie(2 entities) | 23 | $344 |
| Sunovion Pharmaceuticals Inc. | 17 | $255 |
| Livanova USA, Inc. | 13 | $248 |
| MDD US Operations, LLC | 9 | $247 |
| Acadia Pharmaceuticals Inc | 14 | $246 |
| UCB, Inc. | 12 | $245 |
| Amgen | 8 | $244 |
| Amneal Pharmaceuticals LLC | 14 | $238 |
| Medtronic | 2 | $229 |
| Lilly USA, LLC | 11 | $206 |
| Abbott | 7 | $176 |
| Mallinckrodt Enterprises LLC | 6 | $166 |
| Promius Pharma LLC | 1 | $125 |
| Bausch Health US, LLC | 5 | $109 |
| Lundbeck LLC | 5 | $85 |
| Neurocrine Biosciences, Inc. | 4 | $69 |
| Assertio Therapeutics, Inc. | 5 | $68 |
| Upsher-smith Laboratories LLC | 3 | $56 |
| GE HealthCare | 3 | $55 |
| CSL Behring | 3 | $53 |
| Merz North America, Inc. | 3 | $52 |
| Acorda Therapeutics, Inc | 2 | $46 |
| Kyowa Kirin, Inc. | 2 | $40 |
| Vertical Pharmaceuticals, LLC | 2 | $32 |
| Mallinckrodt Hospital Products Inc. | 1 | $32 |
| Adamas Pharmaceuticals, Inc. | 2 | $30 |
| Boston Scientific | 1 | $26 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Tanabe Pharma America, Inc. | 1 | $14 |
| Grifols USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,098 in reported general payments places this provider in the 70th percentile of 1,246 neurology providers in Texas.
Other neurology in Cleveland
- Ann BassSan Antonio$1.7M
- William OndoHouston$1.4M
- Nirav PavasiaDallas$1.4M
- Mirla AvilaLubbock$1.3M
- Michael SoileauGeorgetown$1.2M
- Pankaj SatijaHouston$1.1M
- Annette HowardHouston$826K
- Benjamin GreenbergDallas$773K
- Annette OkaiPlano$730K
- Waleed El-FekyDallas$587K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.